CHUS - Hôtel-Dieu

Sherbrooke

1 studies enrolling now · 1 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Cancer

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now